Abstract:Cornelia de Lange syndrome (CdLS; OMIM: 122470) is characterized by distinctive facial features, growth retardation, hirsutism, and upper limb reduction defects. Craniofacial features manifest as synophrys, arched eyebrows, long thick eyelashes, a small upturned nose, small widely-spaced teeth, and microcephaly. The intelligence quotient (IQ) is usually below the normal level. More phenotypes are frequently found, such as cardiac septal defects, gastrointestinal dysfunction, hearing loss, myopia, and cryptorchidism or hypoplastic genitalia. Some individuals suffering from milder forms of CdLS have less severe growth, cognitive, and limb involvement, but often have typical facial features.1 The prevalence of CdLS is estimated to be 1.6 to 2.2/100 000 live births, without racial variation.2 Most cases are sporadic, and very few familial cases have been reported. Approximately 50%-60% of CdLS cases are caused by mutations in the Nipped-B-like (NIPBL) gene, which encode two isoform products termed delangin-A and delangin-B. Mutations in the Structural Maintenance of Chromosomes 1A (SMC1A) and 3 (SMC3) genes account for ˜5% of CdLS cases and have been shown to cause a consistently mild phenotype.3 All three genes encode components of the sister chromatid cohesin complex. A diagnosis of CdLS is based on not only clinical findings, but also molecular genetic testing. Here, we report the first molecular analysis of a young patient diagnosed with CdLS in China. A 3-year-old girl with multiple congenital anomalies was referred to our clinic. The patient presented typical facial features: arch-like confluent eyebrows, long thick eyelashes, low anterior and posterior hairlines, anteverted nares, collapsed nasal bridge, downturned corners of the mouth, thin lips and low-set ears. She also had microcephaly, small hands with the right missing one digit and the left missing two, hirsutism, and a short neck (Figure 1A and 1B). The girl had developmental delay and mental retardation. She was the first child of her parents who denied a consanguineous relationship, following a first, uneventful pregnancy. There was no positive history of any deformity in the parents' families.Figure 1.: Characteristic features of the CdLS patient and sequencing of the NIPBL gene. A: Arch-like confluent eyebrows, long thick eyelashes, anteverted nares, collapsed nasal bridge, downturned corners of the mouth, thin lips and low-set ears. B: Upper-limb abnormalities. C: Chromographs of the partial cDNA sequence of NIPBL from the patient (upper) and a healthy individual (lower) showing a heterozygous 4-base deletion in exon 44 (c. 7423_7426delGACA) (black arrow).Venous blood samples were obtained from all the family members and 100 unrelated healthy individuals. Genomic DNA was extracted following a standard protocol. The coding exons and flanking intronic sequences of NIPBL (exons 2-47), SMC1A (exons 1-25) and SMC3 (exons 1-29) were amplified by PCR and bidirectional Sanger sequencing. This study was conducted in conformity with the Declaration of Helsinki and approved by Zhejiang University Review Board, and informed consent was given by all participating individuals. Sequencing analysis of the patient revealed a heterozygous, 4-base deletion (c.7423_7426delGACA) in exon 44 of NIPBL, which resulted in a frame-shift, leading to premature termination at codon 2504 (Figure 1C). The variant was not detected in the parents of our patient and the controls, suggesting a de novo event. No mutations in SMC1A or SMC3 were found. NIPBL is located at chromosome 5p13.1. It spans 189 kb of genomic DNA, and is composed of 47 exons. NIPBL is a novel protein displaying homology to Drosophila nipped-B and yeast sister chromatid cohesion protein 2 (scc2).4 The normal NIPBL molecule appears to play a role in sister chromatid cohesion and in regulating long-range enhancer-promoter interactions, possibly through interactions with the cohesin complex.5 To date, more than 80 causative mutations have been reported in patients with CdLS: 20% missense, 40% frame-shift, 20% nonsense, and 15% splice-site mutations (Human Genome Mutation Database: www.hgmd.cf.ac.uk). These mutations may cause loss-of-function alleles, and the severity of phenotypes generally correlates with the type of mutation.3 Analysis of genotype-phenotype associations demonstrated a trend toward a more severe phenotype in patients with nonsense or frame-shift mutations vs. patients with missense mutations or in-frame deletions, especially if the mutations occur in critical domains of the protein.3 In this study, we described the molecular genetic diagnosis of a Chinese girl with classic (severe) CdLS. She carried a heterozygous 4-based deletion (c.7423_7426delGACA) in NIPBL. According to the information available in the Human Genome Mutation Database and to the best of our knowledge, this is a novel de novo mutation of NIPBL that has not been reported elsewhere. The present case is consistent with previous genetic observations in other patients and provides further evidence that more severe symptoms are associated with more severe mutations, especially the frame-shift mutation type, in NIPBL. Because it is a heavy burden for society and families to raise these children, it is appropriate to offer genetic counseling to pedigrees which are affected or at risk. Generally, when the parents of an affected child are apparently clinically unaffected, the risk to the siblings of a child with CdLS has been estimated to be about 1.5% because of the possibility of germline mosaicism. Thus, the determination of genetic risk and discussion of the availability of prenatal testing should be provided before the next pregnancy. Our findings would facilitate family counseling and more definitive predictive prognosis.

Mutation profiling in South African patients with Cornelia de Lange syndrome phenotype

Clinical and molecular analysis in a cohort of Chinese children with Cornelia de Lange syndrome

Hidden Mutations in Cornelia de Lange Syndrome Limitations of Sanger Sequencing in Molecular Diagnostics

Neurobehavioral and developmental profiles: genotype–phenotype correlations in individuals with Cornelia de Lange syndrome

Next‐generation phenotyping in Nigerian children with Cornelia de Lange syndrome

Next-generation phenotyping in Nigerian children with Cornelia de Lange Syndrome

Mutation analysis and clinical profile of South African patients with Neurofibromatosis type 1 (NF1) phenotype

A Novel de Novo Variant in 5′ UTR of the NIPBL Associated with Cornelia de Lange Syndrome

A Novel De Novo Mutation of the Nipped-B-like Gene in an Isolated Chinese Patient with Cornelia De Lange Syndrome.

Cornelia de Lange syndrome, related disorders, and the Cohesin complex: Abstracts from the 8th biennial scientific and educational symposium 2018

A Multidisciplinary Pediatric Case Series and Review of the Literature

Exome Sequencing Identifies a De Novo Mutation in HDAC8 Associated with Cornelia De Lange Syndrome.

The mutational profile in a South African cohort with inherited neuropathies and spastic paraplegia

Genomic Duplication Resulting in Increased Copy Number of Genes Encoding the Sister Chromatid Cohesion Complex Conveys Clinical Consequences Distinct from Cornelia De Lange

Audiological Characterization of Individuals with Cornelia de Lange Syndrome

BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer

Evaluating Face2Gene as a Tool to Identify Cornelia de Lange Syndrome by Facial Phenotypes

Cornelia de Lange syndrome and the Cohesin complex: Abstracts from the 9th Biennial Scientific and Educational Virtual Symposium 2020

Heterozygous loss-of-function SMC3 variants are associated with variable and incompletely penetrant growth and developmental features

Heterozygous loss-of-function SMC3 variants are associated with variable growth and developmental features

Whole-genome sequencing reveals de-novo mutations associated with nonsyndromic cleft lip/palate